Yahoo Web Search

Search results

  1. Noubar Afeyan ( Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. [1] [2] He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.

  2. Noubar Afeyan is founder and CEO of Flagship Pioneering. He is also co-founder and Board Chairman of Moderna. Founded in 2000, Flagship is an enterprise where entrepreneurially-minded scientists invent seemingly unreasonable solutions to challenges facing human health and sustainability.

  3. www.forbes.com › profile › noubar-afeyanNoubar Afeyan - Forbes

    1 day ago · Noubar Afeyan is the founder and CEO of Cambridge, Mass. life sciences innovation firm Flagship Pioneering. He's also the chairman and cofounder of biotech firm Moderna,...

  4. Jan 6, 2021 · Noubar Afeyan is the cofounder and chairman of biotech firm Moderna, whose coronavirus vaccine is close to getting approval in the US from the FDA.

  5. Jul 3, 2021 · As the delta Covid variant spreads, Moderna co-founder Noubar Afeyan explains how his company was able to deploy an mRNA vaccine in less a year.

  6. Oct 11, 2021 · Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a way to deploy the messenger RNA molecule to tackle...

  7. View Noubar Afeyans profile on LinkedIn, a professional community of 1 billion members. Flagship Pioneering is a biotechnology company that invents and builds platform…

    • Flagship Pioneering
  8. Sep 23, 2021 · Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not as a stroke...

  9. Noubar Afeyan. Co-Founder and Chairman, Moderna. Dr. Noubar Afeyan is founder and CEO of Flagship Pioneering, a company that conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability.

  10. May 30, 2024 · Commencement address by Noubar Afeyan PhD ’87. “Welcome long odds,” the biotechnology leader urged the Class of 2024. “Embrace uncertainty, and lead with imagination.”. The inventor, entrepreneur, and philanthropist has co-founded and developed over 70 life-science and technology startups.